Interestingly, we found that the dominance of tumor cell expression on systemic serum levels was independent of the percentage IDO-positive tumor cells (Figure 3D), but that the serum kyn/trp ratio was apparently determined by the different IDO expression patterns of the PT. The gene discussed is IDO1; the disease is neoplasm.